Epidermal growth factor receptor tyrosine kinase inhibitors and depression

J Clin Oncol. 2009 Aug 10;27(23):e49-50; author reply e51. doi: 10.1200/JCO.2009.22.5219. Epub 2009 Jul 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Depression / chemically induced*
  • Depression / enzymology
  • ErbB Receptors / antagonists & inhibitors*
  • Erlotinib Hydrochloride
  • Gefitinib
  • Humans
  • Lung Neoplasms / drug therapy
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / adverse effects*
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Quinazolines / adverse effects

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Quinazolines
  • Erlotinib Hydrochloride
  • ErbB Receptors
  • Protein-Tyrosine Kinases
  • Gefitinib